The 105 references in paper S. Avdeev N., С. Авдеев Н. (2014) “Хроническая обструктивная болезнь легких: обострения // Acute exacerbation of chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2013:i:3:p:5-19

1
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. Last updated 2013. www.goldcopd.org
(check this in PDF content)
2
Hurst J.R., Vestbo J., Anzueto A. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010; 363: 1128–1138.
(check this in PDF content)
3
Stanford R.H., Shen Y., McLaughlin T.Cost of chronic obstructive pulmonary disease in the emergency department and hospital: an analysis of administrative data from 218 US hospitals. Treat. Respir. Med. 2006; 5: 343–349.
(check this in PDF content)
4
O'Donnell D.E., Parker C.M. COPD exacerbations: Pathophysiology. Thorax 2006; 61: 354–361.
(check this in PDF content)
5
Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzi, cha J.A.Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–852.
(check this in PDF content)
6
Seemungal T.A.R., Donaldson G.C., Paul E.A. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 151: 1418–1422.
(check this in PDF content)
7
Miravitlles M., Murio C., Guerrero T. et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121: 1449–1455.
(check this in PDF content)
8
Celli B.R., Barnes P.J.Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 2007; 29: 1224–1238.
(check this in PDF content)
9
Zielinski J., MacNee W., Wedzicha J. et al.Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch. Chest Dis. 1997; 52: 43–47.
(check this in PDF content)
10
Seneff M.G., Wagner D.P., Wagner R.P. et al.Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. J.A.M.A. 1995; 274: 1852–1857.
(check this in PDF content)
11
Connors A.F. Jr, Dawson N.V., Thomas C. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am. J. Respir. Crit. Care Med. 1996; 154: 959–967.
(check this in PDF content)
12
Wouters E.F. The burden of COPD in The Netherlands: results from the Confronting COPD survey. Respir. Med. 2003; 97 (Suppl. C): S51– S59.
(check this in PDF content)
13
Gunen H., Hacievliyagil S.S., Kosar F. et al. Factors affecting survival of hospitalised patients with COPD. Eur. Respir. J. 2005; 26: 234–241.
(check this in PDF content)
14
Kong G.K., Belman M.J., Weingarten S.Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. Chest 1997; 111: 89–94.
(check this in PDF content)
15
Han M.K., Agusti A., Calverley P.M. et al. COPD phenotypes: The future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182: 598–604.
(check this in PDF content)
16
Suissa S., Dell'aniello S., Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67: 957–963.
(check this in PDF content)
17
Eeden S.F., Sin D.D. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75: 224–238.
(check this in PDF content)
18
Harvey M.G., Hancox R.J. Elevation of cardiac troponins in exacerbation of chronic obstructive pulmonary disease. Emerg. Med. Australasia 2004; 16: 212–215.
(check this in PDF content)
19
Donaldson G.C., Hurst J.R., Smith C.J. et al.Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010; 137: 1091–1097.
(check this in PDF content)
20
McAllister D.A., Maclay J.D., Mills N.L. et al. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur. Respir. J. 2012; 39: 1097–1103.
(check this in PDF content)
21
Chang C.L., Robinson S.C., Mills G.D. et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 2011; 66: 764–768.
(check this in PDF content)
22
Rodriguez,Roisin R.Toward a consensus definition for COPD exacerbation. Chest 2000; 117: 398S–401S.
(check this in PDF content)
23
Steer J., Gibson J., Bourke S.C.The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 2012; 67: 970–976.
(check this in PDF content)
24
Papi A., Bellettato C.M., Braccioni F. et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 2006; 173: 1114–1121.
(check this in PDF content)
25
Veeramachaneni S.B., Sethi S.Pathogenesis of bacterial exacerbations of COPD. COPD 2006; 3: 109–115. Передовая статья
(check this in PDF content)
26
Rosell A., Monso E., Soler N. et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch. Intern. Med. 2005; 165: 891–897.
(check this in PDF content)
27
Sethi S., Sethi R., Eschberger K. et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 176: 356–361.
(check this in PDF content)
28
Sethi S., Evans N., Grant B.J.B., Murphy T.F.New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 2002; 347: 465–471.
(check this in PDF content)
29
Murphy T.F., Brauer A.L., Grant B.J., Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am. J. Respir. Crit. Care Med. 2005; 172: 195–199.
(check this in PDF content)
30
Murphy T.F., Brauer A.L., Sethi S. et al.Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae. J. Infect. Dis. 2007; 195: 81–89.
(check this in PDF content)
31
Murphy T.F., Brauer A.L., Eschberger K. et al. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008; 177: 853–60.
(check this in PDF content)
32
Anzueto A. The pathogenesis of acute infection in COPD. Breathe 2009; 5: 311–315.
(check this in PDF content)
33
Seemungal T., Harper,Owen R., Bhowmik A. et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 1618–1623.
(check this in PDF content)
34
Bhowmik A., Seemungal T.A., Sapsford R.J. et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55: 114–120.
(check this in PDF content)
35
Seemungal T.A., Donaldson G.C., Bhowmik A. et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 161: 1608–1613.
(check this in PDF content)
36
Rohde G., Wiethege A., Borg I. et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003; 58: 37–42.
(check this in PDF content)
37
Nichol K.L., Baken L., Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann. Intern. Med. 1999; 130: 397–403.
(check this in PDF content)
38
Donaldson G.C., Seemungal T., Jeffries D.J. et al. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur. Respir. J. 1999; 13: 844–849.
(check this in PDF content)
39
Lyon J.L., Stoddard G., Ferguson D. et al.An every other year cyclic epidemic of infants hospitalized with respiratory syncytial virus. Pediatrics 1996; 97: 152–153.
(check this in PDF content)
40
Meerhoff T.J., Paget J.W., Kimpen J.L. et al.Variation of respiratory syncytial virus and the relation with meteorological factors in different winter seasons. Pediatr. Infect. Dis. J. 2009; 28: 860–866.
(check this in PDF content)
41
Schwartz J. Air pollution and daily mortality: a review and a meta-analysis. Environ. Res. 1994; 64: 36–52.
(check this in PDF content)
42
Zanobetti A., Schwartz J., Dockery D.W.Airborne particles are a risk factor for hospital admissions for heart and lung disease. Environ. Hlth Perspect. 2000; 108: 1071–1077.
(check this in PDF content)
43
Sunyer J., Saez M., Murillo C. et al.Air pollution and emergency room admission for chronic obstructive pulmonary disease: a 5-year study. Am. J. Epidemiol. 1993; 137: 701–705.
(check this in PDF content)
44
Bafadhel M., McKenna S., Terry S. et al.Acute exacerbations of chronic obstructive pulmonary disease. Identification of biologic clusters and their biomarkers. Am. J. Respir. Crit. Care Med. 2011; 184: 662–671.
(check this in PDF content)
45
Aaron S.D., Donaldson G.C., Whitmore G.A. et al.Time course and pattern of COPD exacerbation onset. Thorax 2012; 67: 238–243.
(check this in PDF content)
46
Siefkin A.D. Optimal pharmacologic treatment of the critically ill patients with obstructive airways disease. Am. J. Med. 1996; 100 (Suppl. 1A): 54S–61S.
(check this in PDF content)
47
Parker C.M., Voduc N., Aaron S.D. et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur. Respir. J. 2005; 26: 420–428.
(check this in PDF content)
48
Rodriguez,Roisin R.COPD exacerbations: management. Thorax 2006; 61: 535–544.
(check this in PDF content)
49
McCrory D.C., Brown C.D. Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2003; (1): Art. No: CD003900. DOI: 10.1002/14651858.CD003900.
(check this in PDF content)
50
Cuvelier A., Muir J.F., pour le groupe multicentrique. Apport de la nebulisation dans les exacerbations des bronchopneumopathies chroniques obstructives: place des anticholinergiques. Ann. Fr. Anesth. Reanim. 1998; 17 (Suppl. 2): 48–51.
(check this in PDF content)
51
Karpel J.P. The use of anticholinergic drugs in acute exacerbations of chronic obstructive pulmonary disease. In: Gross N.J., ed. Anticholinergic therapy in obstructive airways disease. London: Franklin Scientic Publications; 1993. 145–154.
(check this in PDF content)
52
Bach P.B., Brown C., Gelfand S.E., McCrory D.C. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann. Intern. Med. 2001; 134: 600–620.
(check this in PDF content)
53
O'Donnell D.E., Aaron S., Bourbeau J. et al. State of the Art Compendium: Canadian Thoracic Society DE recommendations for the management of chronic obstructive pulmonary disease. Can. Respir. J. 2004; 11 (Suppl. B): 7B–59B.
(check this in PDF content)
54
COPD Guideline Working Group of the South African Thoracic Society. Guideline for the management of Chronic Obstructive Pulmonary Disease (COPD): 2004 Revision. S. Afr. Med. J. 2004; 94: 559–575.
(check this in PDF content)
55
Willaert W., Daenen M., Bornans P. et al.What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations? Eur. Respir. J. 2002; 19: 928–935.
(check this in PDF content)
56
Guerin C., Chevre A., Dessirier P. et al. Inhaled fenoterolipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 1036–1042.
(check this in PDF content)
57
Авдеев С.Н., Нуралиева Г.С., Батын С.З. и др. Эффективность комбинированной терапии ингаляционными β2-агонистами и антихолинергическими препаратами при тяжелом обострении хронической обструктивной болезни легких: рандомизированное контролируемое исследование. Пульмонология 2007; 3: 56–65.
(check this in PDF content)
58
Davies L., Angus R.M., Calverley P.M. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Lancet 1999; 354: 456–460.
(check this in PDF content)
59
Maltais F., Ostinelli J., Bourbeau J. et al.Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2002; 165: 698–703.
(check this in PDF content)
60
Niewoehner D.E., Erbland M.L., Deupree R.H. et al. Effect of systemic glucocorticoids on exacerbations of chronic Авдеев С.Н.Хроническая обструктивная болезнь легких: обострения obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N. Engl. J. Med. 1999; 340: 1941–1947.
(check this in PDF content)
61
Thompson W.H., Nielson C.P., Carvalho P. et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am. J. Respir. Crit. Care Med. 1996; 154: 407–412.
(check this in PDF content)
62
Aaron S.D., Vandemheen K.L., Hebert P. et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N. Engl. J. Med. 2003; 348: 2618–2625.
(check this in PDF content)
63
Leuppi J.D., Schuetz P., Bingisser R. et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: The REDUCE randomized clinical trial. J.A.M.A. 2013; 309: 2223–2231.
(check this in PDF content)
64
Bafadhel M., McKenna S., Terry S. et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease. A randomized placebo-controlled trial. Am. J. Respir. Crit. Care Med. 2012; 186: 48–55.
(check this in PDF content)
65
Авдеев С.Н., Суточникова О.А., Белевский А.С., Чуча, лин А.Г. Применение небулизированного будесонида при тяжелом обострении хронической обструктивной болезни легких. Рандомизированное контролируемое исследование. Пульмонология 2003; 5: 81–88.
(check this in PDF content)
66
Gunen H., Hacievliyagil S.S., Yetkin O., Gulbas G. The role of nebulised budesonide in the treatment of acute exacerbations of COPD. Eur. Respir. J. 2007; 30: 399–400.
(check this in PDF content)
67
Baker E.H., Janaway C.H., Philips B.J. et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61: 284–289.
(check this in PDF content)
68
Woodhead M., Blasi F., Ewig S. et al.European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur. Respir. J. 2005; 26: 1138–1180.
(check this in PDF content)
69
O'Donnell D.E., Hernandez P., Kaplan A. et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary care. Can. Respir. J. 2008; 15 (Suppl. A): 1A–8A.
(check this in PDF content)
70
Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196–204.
(check this in PDF content)
71
Celli B.R., MacNee W.; ATS / ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS position paper. Eur. Respir. J. 2004; 23: 932–946.
(check this in PDF content)
72
Weis N., Almdal T.C-reactive protein – can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease. Eur. J. Intern. Med. 2006; 17: 88–91.
(check this in PDF content)
73
Dev D., Sankaran E.W.R., Cunnife J. et al. Value of C-reactive protein in exacerbation of chronic obstructive pulmonary disease. Respir. Med. 1998; 92: 664–667.
(check this in PDF content)
74
Авдеев С.Н., Баймаканова Г.Е., Зубаирова П.А.Возможности С-реактивного белка в диагностике бактериальной инфекции и пневмонии у больных с обострением хронической обструктивной болезни легких. Урал. мед. журн. 2008; 13: 19–24.
(check this in PDF content)
75
Wilson R., Jones P., Schaberg T. et al.Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Thorax 2006; 61: 337–342.
(check this in PDF content)
76
Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 2355–2365.
(check this in PDF content)
77
Козлов Р.С., Сивая О.В., Кречикова О.И. и др. Динамика резистентности Streptococcus pneumoniaeк антибиотикам в России за период 1999–2009 гг. (Результаты многоцентрового проспективного исследования ПеГАС). Клин. микробиол. и антимикроб. химиотер. 2010; 12 (4): 329–341.
(check this in PDF content)
78
Llor C., Moragas A., Hernandez S. et al. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate COPD. Am. J. Respir. Crit. Care Med. 2012; 186: 716–723.
(check this in PDF content)
79
Rogers D.F.Mucoactive agents for airway mucus hypersecretory diseases. Respir. Care 2007; 52: 1176–1193.
(check this in PDF content)
80
Rogers D.F., Barnes P.J.Treatment of airway mucus hypersecretion. Ann. Med. 2006; 38: 116–125.
(check this in PDF content)
81
Hogg J.C., Chu F.S., Tan W.C. et al.Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am. J. Respir. Crit. Care Med. 2007; 176: 454–459.
(check this in PDF content)
82
Авдеев С.Н., Баймаканова Г.Е., Зубаирова П.А. Эффективность терапии карбоцистеином при обострении ХОБЛ. Пульмонология 2012; 6: 96–102.
(check this in PDF content)
83
Zuin R., Palamidese A., Negrin R. et al. High dose N-Acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease. Clin. Drug Invest. 2005; 25: 401–408.
(check this in PDF content)
84
Kane B., Decalmer S., O'Driscoll B.R.Emergency oxygen therapy: from guideline to implementation. Breathe 2013; 9: 247–254.
(check this in PDF content)
85
Bone R.C., Pierce A.K., Johnson R.L. Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: a reappraisal. Am. J. Med. 1978; 65: 896–902.
(check this in PDF content)
86
Mehta S., Hill N.S.Noninvasive ventilation. Am. J. Respir. Crit. Care Med. 2001; 163: 540–577.
(check this in PDF content)
87
Meduri G.U., Conoscenti C.C., Menashe P., Nair S. Noninvasive face mask ventilation in patients with acute respiratory failure. Chest 1989; 95: 865–870.
(check this in PDF content)
88
Авдеев С.Н., Чучалин А.Г. Неинвазивная вентиляция легких при острой дыхательной недостаточности у больных хронической обструктивной болезнью легких. Тер. арх. 2000; 3: 59–65.
(check this in PDF content)
89
Brochard L., Mancebo J., Wysocki M. et al.Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 1995; 333: 817–822.
(check this in PDF content)
90
Kramer N., Meyer T.J., Meharg J. et al.Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am. J. Respir. Crit. Care Med. 1995; 151: 1799–1806.
(check this in PDF content)
91
Авдеев С.Н., Третьяков А.В., Григорьянц Р.А. и др. Исследование применения неинвазивной вентиляции легких при острой дыхательной недостаточности на фоне обострения хронического обструктивного заболевания легких. Анестезиол. реаниматол. 1998; 3: 45–51.
(check this in PDF content)
92
Laghi F., D'Alfonso N., Tobin M.J. Pattern of recovery from diaphragmatic fatigue over 24 hours. J. Appl. Physiol. 1995; 79: 539–546.
(check this in PDF content)
93
Gladwin M.T., Pierson D.J. Mechanical ventilation of the patient with severe chronic obstructive pulmonary disease. Intens. Care Med. 1998; 24: 898–910.
(check this in PDF content)
94
Fagon J.Y., Chastre J., Gibert C. Acute respiratory failure in chronic obstructive pulmonary disease. Bacterial infection Передовая статья as a precipitating factor. In: Derenne J.-P., Whitelaw W.A., Similowski T., eds. Acute respiratory failure. New York: Marcel Dekker Inc.; 1995. 337–389.
(check this in PDF content)
95
Brochard L., Rauss A., Benito S. et al. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am. J. Respir. Crit. Care Med. 1994; 150: 896–903.
(check this in PDF content)
96
Esteban A., Alia I., Gordo F. et al.Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group. Am. J. Respir. Crit. Care Med. 1997; 156: 459–465.
(check this in PDF content)
97
Nava S., Ambrosino N., Clini E. et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann. Intern. Med. 1998; 128: 721–728.
(check this in PDF content)
98
Allan P.F., Osborn E.C., Chung K.K., Wanek S.M. Highfrequency percussive ventilation revisited. J. Burn. Care Res. 2010; 31: 510–520.
(check this in PDF content)
99
Ravez P, Richez M, Godart G.et al. Effect of intermittent high-frequency intra-pulmonary percussive breathing on mucus transport. Eur. J. Respir Dis 1986; 69 (Suppl. 146): 285–289.
(check this in PDF content)
100
Toussaint M., Guillet M.,C., Paternotte S. et al. Intrapulmonary effects of setting parameters in portable intrapulmonary percussive ventilation devices. Respir. Care 2012; 57: 735–742.
(check this in PDF content)
101
Vargas F., Bui H.N., Boyer A. et al.Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: A randomised controlled trial. Crit. Care 2005; 9: R382–R389.
(check this in PDF content)
102
Antonaglia V., Lucangelo U., Zin W.A et al. Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet. Crit. Care Med. 2006; 34: 1–6.
(check this in PDF content)
103
Kempainen R.R., Milla C., Dunitz J. et al.Comparison of settings used for high-frequency chest-wall compression in cystic fibrosis. Respir. Care 2010; 55: 695–699.
(check this in PDF content)
104
Krishnan J., Ridge A., Walker Harris V. et al. Treating exacerbations of asthma or chronic obstructive pulmonary disease (COPD) with high frequency chest wall oscillation (HFCWO) in hospitalized patients. In: European. Respir. Congress; 2010. 3869.
(check this in PDF content)
105
Goktalay T., Akdemir S., Coskun A. et al.Evaluation of contribution of high frequency chest wall oscillation treatment to medical treatment in patients with acute exacerbations of COPD. In: European. Respir. Congress; 2011. 1245.
(check this in PDF content)